References
- Coyle CM, Tanowitz HB. Diagnosis and treatment of neurocysticercosis. Interdiscip Perspect Infect Dis [Internet]. 2009;2009:1–9. [cited 2021 Jan 19]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2734940/
- Rajshekhar V, Raghava MV, Prabhakaran V, et al. Active epilepsy as an index of burden of neurocysticercosis in vellore district, India. Neurology. 2006;67(12):2135–2139.
- Varghese V, Chandra SR, Christopher R, et al. Cognitive dysfunction and its determinants in patients with neurocysticercosis. Indian J Psychol Med. 2016;38(2):142–146.
- Rathore C, Thomas B, Kesavadas C, et al. Calcified neurocysticercosis lesions and antiepileptic drug-resistant epilepsy: a surgically remediable syndrome? Epilepsia. 2013;54(10):1815–1822.
- Robinson P, Garza A, Weinstock J, et al. Substance P causes seizures in neurocysticercosis. PLoS Pathog. 2012;8(2):e1002489.
- Mahajan L, Malhotra HS, Garg RK, et al. Predictors of lesion calcification in patients with solitary cysticercus granuloma and New-Onset seizures. Am J Trop Med Hyg. 2016;95(3):623–628.
- Nash TE, Del Brutto OH, Butman JA, et al. Calcific neurocysticercosis and epileptogenesis. Neurology. 2004;62(11):1934–1938.
- Nash TE, Pretell EJ, Lescano AG, Cysticercosis Working Group in Peru, et al. Perilesional brain oedema and seizure activity in patients with calcified neurocysticercosis: a prospective cohort and nested case-control study. Lancet Neurol. 2008;7(12):1099–1105.
- Gupta RK, Awasthi R, Rathore RKS, et al. Understanding epileptogenesis in calcified neurocysticercosis with perfusion MRI. Neurology. 2012;78(9):618–625.
- Bianchin MM, Velasco TR, Wichert-Ana L, et al. Characteristics of mesial temporal lobe epilepsy associated with hippocampal sclerosis plus neurocysticercosis. Epilepsy Res. 2014;108(10):1889–1895.
- Ko S-W, Lin J-L, Yang H-Y, et al. Massive brain calcifications associated with vitamin D deficiency. Intern Med. 2011;50(21):2693.
- Keasey MP, Lemos RR, Hagg T, et al. Vitamin-D receptor agonist calcitriol reduces calcification in vitro through selective upregulation of SLC20A2 but not SLC20A1 or XPR1. Sci Rep. 2016 May 17;6:25802.
- Consensus Statement: Global Consensus Recommendations on Prevention and Management of Nutritional Rickets [Internet]. [cited 2021 Oct 22]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4880117/.
- Singhi P, Saini AG. Pediatric neurocysticercosis. Indian J Pediatr. 2019;86(1):76–82.
- Bianchin MM, Velasco TR, Takayanagui OM, et al. Neurocysticercosis, mesial temporal lobe epilepsy, and hippocampal sclerosis: an association largely ignored. Lancet Neurol. 2006;5(1):20–21.
- Bern C, Garcia HH, Evans C, et al. Magnitude of the disease burden from neurocysticercosis in a developing country. Clin Infect Dis. 1999;29(5):1203–1209.
- White AC, Coyle CM, Rajshekhar V, et al. Diagnosis and treatment of neurocysticercosis: 2017 clinical practice guidelines by the infectious diseases society of america (IDSA) and the american society of tropical medicine and hygiene (ASTMH). Clin Infect Dis. 2018;66(8):e49–e75.
- Fisher RS, Cross JH, French JA, et al. Operational classification of seizure types by the international league against epilepsy: Position paper of the ILAE commission for classification and terminology. Epilepsia. 2017;58(4):522–530.
- Wang W. Combined antiparasitic treatment for neurocysticercosis. Lancet Infect Diseases. 2015;1;15(3):265–266.
- Bustos JA, Arroyo G, Gilman RH, et al. Frequency and determinant factors for calcification in neurocysticercosis. Clin Infect Dis. 2021;73:e2592–e2600..
- Ngugi AK, Bottomley C, Kleinschmidt I, et al. Estimation of the burden of active and life-time epilepsy: a Meta-analytic approach. Epilepsia. 2010 May;51(5):883–890.
- Vogiatzi MG, Jacobson-Dickman E, DeBoer MD, Drugs, and Therapeutics Committee of The Pediatric Endocrine Society Drugs, and therapeutics committee of the pediatric endocrine society. Vitamin D supplementation and risk of toxicity in pediatrics: a review of current literature. J Clin Endocrinol Metab. 2014;99(4):1132–1141.
- Cesur Y, Caksen H, Gündem A, et al. Comparison of low and high dose of vitamin D treatment in nutritional vitamin D deficiency rickets. J Pediatr Endocrinol Metab. 2003;16(8):1105–1109.
- Tannous P, Fiscaletti M, Wood N, et al. Safety and effectiveness of stoss therapy in children with vitamin D deficiency. J Paediatr Child Health. 2020;56(1):81–89.
- Chavhan SG, Brar RS, Banga HS, et al. Clinicopathological studies on vitamin D(3) toxicity and therapeutic evaluation of aloe vera in rats. Toxicol Int. 2011;18(1):35–43.
- Payne ME, Anderson JJB, Steffens DC. Calcium and vitamin D intakes may be positively associated with brain lesions in depressed and nondepressed elders. Nutr Res. 2008;28(5):285–292.